Testing FIT-DNA to guide follow-up after colon cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial checks a stool test called FIT-DNA after colorectal (colon) cancer surgery. It aims to see whether this test can help doctors monitor for recurrence during follow-up and decide how closely to watch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with colorectal adenocarcinoma (a common type of colon cancer)
- You are between 18 and 80 years old and can take part in follow-up visits
- You need curative (radical) colorectal surgery, and scans before surgery did not show spread to distant organs
- You did not receive cancer treatment before surgery (like chemo, radiation, targeted drugs, or immunotherapy)
- You don’t have major ongoing stomach or rectal bleeding issues before surgery (for example, severe hemorrhoids)
- You agree to sign consent and follow the study’s follow-up plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different ways to screen healthy adults aged 45–74 for colorectal cancer using non-invasive tests. If you join, you will help find the best method to catch cancer early and prevent it.
This study checks a “cell-free tumor DNA” blood test to see if cancer mutations can predict relapse after surgery for early colorectal cancer. If results look risky, they may help guide closer follow-up and future treatment decisions.
This study looks at a blood “DNA” test to see if it can help monitor colorectal cancer after surgery. It may benefit you by improving how doctors track cancer during routine follow-up visits.
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
This trial uses a blood test (liquid biopsy) to look for tiny bits of cancer DNA remaining after surgery. It aims to see if this test can help guide follow-up and treatment decisions for people with colorectal cancer.
This trial tests a program to help people who had an abnormal FIT stool test follow through with getting a colonoscopy. The goal is to improve cancer screening by providing extra support through a care team and technology.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.